ICU Medical Inc (ICUI) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

ICU Medical Inc

NASDAQ | ICUI

141.57

USD

+1.19 (+0.85%)

AT CLOSE (AS OF Apr 3, 2025)

$3.5B

MARKET CAP

P/E Ratio

-4.83

EPS

$196

52 Week High

$93

52 Week Low

LIFE SCIENCES

Sector

ICUI Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

ICUI Technicals

Tags:

ICUI Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$740M
Total Revenue	$2.3B
Cost Of Revenue	$1.5B
Costof Goods And Services Sold	$1.5B
Operating Income	$23M
Selling General And Administrative	$607M
Research And Development	$85M
Operating Expenses	$717M
Investment Income Net	-$17K
Net Interest Income	-$95M
Interest Income	$7.5M
Interest Expense	$103M
Non Interest Income	-$14M
Other Non Operating Income	-
Depreciation	$97M
Depreciation And Amortization	$133M
Income Before Tax	-$78M
Income Tax Expense	-$49M
Interest And Debt Expense	$103M
Net Income From Continuing Operations	$66M
Comprehensive Income Net Of Tax	-$1.8M
Ebit	$24M
Ebitda	$158M
Net Income	-$30M

Revenue & Profitability

Earnings Performance

ICUI Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$4.4B
Total Current Assets	$1.2B
Cash And Cash Equivalents At Carrying Value	$254M
Cash And Short Term Investments	$255M
Inventory	$709M
Current Net Receivables	$162M
Total Non Current Assets	$3.2B
Property Plant Equipment	$613M
Accumulated Depreciation Amortization Ppe	$624M
Intangible Assets	$2.3B
Intangible Assets Excluding Goodwill	$871M
Goodwill	$1.5B
Investments	$10M
Long Term Investments	$3.1M
Short Term Investments	$501K
Other Current Assets	$3.7M
Other Non Current Assets	$94M
Total Liabilities	$2.3B
Total Current Liabilities	$482M
Current Accounts Payable	$150M
Deferred Revenue	$84M
Current Debt	$51M
Short Term Debt	$71M
Total Non Current Liabilities	$1.7B
Capital Lease Obligations	$2M
Long Term Debt	$4.9B
Current Long Term Debt	$51M
Long Term Debt Noncurrent	$1.6B
Short Long Term Debt Total	$1.6B
Other Current Liabilities	$215M
Other Non Current Liabilities	$100M
Total Shareholder Equity	$2.1B
Treasury Stock	$262K
Retained Earnings	$808M
Common Stock	$2.4M
Common Stock Shares Outstanding	$24M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (USD)
Operating Cashflow	$166M
Payments For Operating Activities	$164M
Proceeds From Operating Activities	-
Change In Operating Liabilities	-$58M
Change In Operating Assets	-$30M
Depreciation Depletion And Amortization	$229M
Capital Expenditures	$94M
Change In Receivables	-$49M
Change In Inventory	$6.1M
Profit Loss	$66M
Cashflow From Investment	-$88M
Cashflow From Financing	-$36M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	$9.4M
Payments For Repurchase Of Equity	$9.4M
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$9.4M
Dividend Payout Common Stock	$9.4M
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$5.3M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$30M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$740M
Total Revenue	$2.3B
Cost Of Revenue	$1.5B
Costof Goods And Services Sold	$1.5B
Operating Income	$23M
Selling General And Administrative	$607M
Research And Development	$85M
Operating Expenses	$717M
Investment Income Net	-$17K
Net Interest Income	-$95M
Interest Income	$7.5M
Interest Expense	$103M
Non Interest Income	-$14M
Other Non Operating Income	-
Depreciation	$97M
Depreciation And Amortization	$133M
Income Before Tax	-$78M
Income Tax Expense	-$49M
Interest And Debt Expense	$103M
Net Income From Continuing Operations	$66M
Comprehensive Income Net Of Tax	-$1.8M
Ebit	$24M
Ebitda	$158M
Net Income	-$30M

ICUI Profile

ICU Medical Inc Profile

Sector: LIFE SCIENCES

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	742,693,504
NVDA	$101.80	-7.81%	$2.68T	338,769,412
INTC	$22.43	2.05%	$95.85B	240,924,655
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	211,931,403

Symbol	Price	Change %	Market Cap	Volume
JNJ	$159.81	2.86%	$399.65B	13,235,689
PG	$172.39	1.71%	$399.61B	9,393,270
ABBV	$201.64	-1.73%	$364.89B	7,580,327
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$73.92	2.35%	$225.70B	7,926,952

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$744.62K	310,904
MKTW	$9.23	1,692.58%	$19.91M	126,841
MRM	$0.69	87.76%	$2.91M	54,062,078
PTIX	$0.42	84.14%	$4.04M	177,332,811
OSRH	$2.47	68.03%	$40.06M	89,499,750

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,941,899
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
ICCT	$2.07	-56.14%	$9.78M	12,637,345

Quick Links

ICUI $141.57 (+0.85%) Quote details